Medical/Pharmaceuticals

Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress

Announces Major Milestones at the JPM Healthcare Conference SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Psylo, a leader in neurotherapeutics discovery and development, has officially rebranded asXylo Bio . This transformation reflects the company's growth, sharpened focus ...

2025-01-10 21:00 1976

Sciwind Biosciences Announces Global Licensing and Collaboration Agreement for Metabolic Disease Portfolio

HANGZHOU, China, Jan. 10, 2025 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, today announced a licensing and collaboration agreement for the global development and commercializa...

2025-01-10 15:00 2756

SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA

SEOUL, South Korea, Jan. 10, 2025 /PRNewswire/ -- SN BioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a Phase1b/2 clinical trial. This achievement follows the designation of SNB-101 as...

2025-01-10 14:40 2226

In 2024, Complete Genomics expanded U.S. manufacturing and technology capabilities toward a diversified, reliable supply chain for its flexible and cost-effective NGS solutions

SAN JOSE, Calif., Jan. 9, 2025 /PRNewswire/ -- In 2024, Complete Genomics, a pioneering genomic sequencing company, expanded its U.S. manufacturing footprint with augmented technology capabilities to diversify its supply chain helping it to continue reliably serving customers with flexible, cost-...

2025-01-10 01:43 2898

United Imaging Announces Major Expansion of U.S. Manufacturing Space

The additional space will more than triple the square footage of the company's current production facility and headquarters inHouston, Texas HOUSTON, Jan. 9, 2025 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has signed on for additional ...

2025-01-10 01:00 2139

Goertek Unveils Next-Generation Smart Ring Reference Designs: A Leap Forward in Health Monitoring and Interactive Technology

LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- Recent technological advancements in sensing, big data, cloud computing, IoT, and AI have significantly enhanced the capabilities of wearable devices in health monitoring. Goertek's latest smart ringreference designs, showcased at CES 2025, embodies these i...

2025-01-09 23:00 3015

Hengdian Group Capital and Apeloa Pharmaceutical to participate in 2025 J.P. Morgan Healthcare Conference

HANGZHOU, China, Jan. 9, 2025 /PRNewswire/ -- Hengdian Group Capital (HgC) and Apeloa Pharmaceutical (subsidiaries of Hengdian Group) will attend the 43rd Annual J.P. Morgan Healthcare Conference inSan Francisco from January 13-16, 2025. HgC CEO Gary Xu and Apeloa VP George Cai will be present a...

2025-01-09 22:00 2593

Anbio Biotechnology Unveils Dry Chemiluminescence Immunoassay (CLIA) Solution: Redefining Diagnostic Precision and Efficiency

FRANKFURT, Germany, Jan. 9, 2025 /PRNewswire/ -- Anbio Biotechnology ("Anbio"), a global leader in diagnostics innovation, announces the launch of its Dry Chemiluminescence Immunoassay (CLIA) Solution ADL-1000, a transformative technology designed to deliver rapid, reliable, and cost-effective di...

2025-01-09 16:04 2062

RiDYMO® Designs Cyclic Peptide for "Undruggable" β-Catenin Target Within Two Months

BEIJING, Jan. 8, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically "undruggable" protein, in just two months. This innovative AI-driven approach combines advanced algorithms, ...

2025-01-09 12:35 2208

Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development

* Samsung Biologics to offer ADC services at new dedicated facility * Extended collaboration reflects successful partnership and expertise INCHEON,South Korea, Jan. 8, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO),...

2025-01-09 08:57 2327

Wondfo Brings Fast and Reliable Rapid Testing Solution Brands to CES 2025

LAS VEGAS, Jan. 8, 2025 /PRNewswire/ -- Wondfo USA Co., Ltd. ("Wondfo" or "Company"), a leading brand in medical diagnostic testing solutions and technologies, showcased its commitment to the North American market by presenting a diverse range of products at CES 2025. The WondfoUSA WELLlife and ...

2025-01-09 01:00 1801

I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member

Chairman of the Board, Wei Fu, informed the Company of his intent to purchase up to$2,000,000 of the Company's American Depository Shares (ADSs) ROCKVILLE, Md., Jan. 8, 2025 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of ...

2025-01-08 20:00 1888

111, Inc. Announces ADS Ratio Change

SHANGHAI, Jan. 8, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream inChina, today announced that it plans to ch...

2025-01-08 18:00 2189

Alma Harmony Wins European Product Design Award in Healthcare Category

CAESAREA, Israel, Jan. 8, 2025 /PRNewswire/ -- Alma Lasers , a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, today announced that its groundbreaking multi-platform aesthetic solution, Alma Harmony, has received the prestigiou...

2025-01-08 17:00 1992

GenScript Biotech Becomes a PSCI Supplier Partner, Advancing a Sustainable Pharmaceutical Supply Chain

PISCATAWAY, N.J., Jan. 7, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences research and manufacturing services, has officially joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner. This milestone marks significant progress in GenScript...

2025-01-08 11:30 1814

MedicosBiotech Wins CES 2025 Innovation Award in Digital Health

SEOUL, South Korea, Jan. 7, 2025 /PRNewswire/ -- MedicosBiotech proudly announces its recognition at CES 2025, the world's premier technology event, as a recipient of the prestigious CES Innovation Award in the Digital Health category. This award honors excellence in innovation, technology, and d...

2025-01-08 01:00 3084

Insilico Received Positive Topline Results from Two Phase 1 Trials of ISM5411, New Drug Designed Using Generative AI for the Treatment of Inflammatory Bowel Disease

* Two separate Phase I studies conducted in Australia and in China indicate that ISM5411 was generally safe and well tolerated in all dose groups, demonstrating a favorable PK profile in validating gut-restrictive properties. * Supported by Insilico's commercially-available generative AI platf...

2025-01-07 22:00 2141

Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing

SHANGHAI and YANGZHOU, China, Jan. 7, 2025 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for renal diseases and related chronic conditions, announced the closing ...

2025-01-07 21:00 2159

U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application

* If approved, Sunvozertinib as a single oral drug would offer a convenient and safe treatment option with superior efficacy for NSCLC patients with EGFR exon20ins * Sunvozertinib's NDA was submitted based on the multinational pivotal WU-KONG1 Part B study, the results of which were presented...

2025-01-07 18:00 2108

Akeso to Share Global Strategy for New Drug Development at the 43rd J.P. Morgan Healthcare Conference

HONG KONG and SAN FRANCISCO, Jan. 6, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference, taking place onJanuary 13, 2025, in San Francisco, California. The company's founder, ...

2025-01-07 11:18 2047
1 ... 59606162636465 ... 251

Week's Top Stories